The IMPACT Collaboratory released two new Requests for Applications (RFAs) for conducting pragmatic trials in persons with AD/ADRD on April 20:
In response to the coronavirus disease (COVID-2019) outbreak, in this award cycle, the IMPACT Collaboratory will prioritize applications proposing pilot ePCTs of telemedicine, telehealth, and remote technologies interventions aimed at improving health outcomes for persons living with dementia and their caregivers. Applications for other types non-pharmacological interventions will also be considered.
Mandatory letters of intent are due May 29, 2020 and will be reviewed on a rolling basis. Full proposal applications are by invitation only and are due September 4, 2020.
For more information, pre-register now to participate in one of two optional webinars by clicking on your preferred date below:
April 28, 2020 at 1:30 p.m. ET
NIA plans for another RFA for 1-year pilot studies in September 2020.
- Request for Applications for 2-year career development awards to support the development of early-stage MD, PhD, or equivalent researchers who seek careers conducting ePCTs for people living with AD/ADRD and their caregivers
Each award will provide $100,000 annually in direct costs. Awardees are required to devote a minimum of 75% effort toward the goals of the award. Letters of intent are not required. Full proposal applications are due July 15, 2020.
For more information, pre-register now to participate in one of two optional webinars by clicking on your preferred date below:
April 29, 2020 at 3:00 p.m. ET
To learn more about pilot study and career development award programs and the IMPACT Collaboratory, visit the website, email the team, or register to attend one or more of the optional webinars linked above.
